Modern therapies for the treatment of type 2 diabetes, such as glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors, have consistently demonstrated efficacy in terms of reducing glycated hemoglobin (HbA1c) levels and body weight, while offering minimal risk of hypoglycemia
Problem: One-time treatments rarely produce lasting results
[DOI] [PubMed] [Google Scholar] 123.Song E.A., Kim H
However, if the pen was exposed to temperatures above 86F (30C) at any point, or if the cumulative room temperature storage exceeds 21 days, the medication should not be used
Targeting glutamine metabolism with a novel Na+/K+-ATPase inhibitor RX108 in hepatocellular carcinoma
If you're of South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean background, you may be eligible at a BMI of 27 or above (instead of 30)